|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Podlodowska J, Szumiło J, Podlodowski W,
Starosławska E and Burdan F: Epidemiology and risk factors of the
oral carcinoma. Pol Merkur Lekarski. 32:135–137. 2012.(In Polish).
PubMed/NCBI
|
|
3
|
Wang Z, Jiang L, Huang C, Li Z, Chen L,
Gou L, Chen P, Tong A, Tang M, Gao F, et al: Comparative proteomics
approach to screening of potential diagnostic and therapeutic
targets for oral squamous cell carcinoma. Mol Cell Proteomics.
7:1639–1650. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Noguti J, De Moura CF, De Jesus GP, Da
Silva VH, Hossaka TA, Oshima CT and Ribeiro DA: Metastasis from
oral cancer: An overview. Cancer Genomics Proteomics. 9:329–335.
2012.PubMed/NCBI
|
|
5
|
Hardy J and Singleton A: Genomewide
association studies and human disease. N Engl J Med. 360:1759–1768.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Habibi I, Sfar I, Kort F, Aounallah-Skhiri
H, Chebil A, Chouchene I, Bouraoui R, Limaiem R, Largheche L,
Jendoubi-Ayed S, et al: Y402H polymorphism in complement factor H
and age-related macular degeneration in the Tunisian population.
Ophthalmic Res. 49:177–184. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Varghese JS and Easton DF: Genome-wide
association studies in common cancers-what have we learnt. Curr
Opin Genet Dev. 20:201–209. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang Q, Wang JY, Zhang XP, Lv ZW, Fu D, Lu
YC, Hu GH, Luo C and Chen JX: RLIP76 is overexpressed in human
glioblastomas and is required for proliferation, tumorigenesis and
suppression of apoptosis. Carcinogenesis. 34:916–926. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tan B, Anaka M, Deb S, Freyer C, Ebert LM,
Chueh AC, Al-Obaidi S, Behren A, Jayachandran A, Cebon J, et al:
FOXP3 over-expression inhibits melanoma tumorigenesis via effects
on proliferation and apoptosis. Oncotarget. 5:264–276. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ma GZ, Liu CH, Wei B, Qiao J, Lu T, Wei
HC, Chen HD and He CD: Baicalein inhibits DMBA/TPA-induced skin
tumorigenesis in mice by modulating proliferation, apoptosis, and
inflammation. Inflammation. 36:457–467. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang J, Cao C, Luo H, Xiong S, Xu Y and
Xiong W: Tumour necrosis factor alpha −308G/A polymorphism and risk
of the four most frequent cancers: A meta-analysis. Int J
Immunogenet. 38:311–320. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kotnis A, Kannan S, Sarin R and Mulherkar
R: Case-control study and meta-analysis of sult1a1 arg213his
polymorphism for gene, ethnicity and environment interaction for
cancer risk. Br J Cancer. 99:1340–1347. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dong LM, Potter JD, White E, Ulrich CM,
Cardon LR and Peters U: Genetic susceptibility to cancer: The role
of polymorphisms in candidate genes. JAMA. 299:2423–2436. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Levine DM, Ek WE, Zhang R, Liu X, Onstad
L, Sather C, Lao-Sirieix P, Gammon MD, Corley DA, Shaheen NJ, et
al: A genome-wide association study identifies new susceptibility
loci for esophageal adenocarcinoma and Barrett's esophagus. Nat
Genet. 45:1487–1493. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hindorff LA, MacArthur J; (European
Bioinformatics Institute), Morales J (European Bioinformatics
Institute), ; Junkins HA, Hall PN, Klemm AK and Manolio TA: A
Catalog of Published Genome-Wide Association Studies. A Catalog of
Published Genome-Wide Association Studies. https://www.genome.gov/gwastudiesSeptember 3–2012
|
|
16
|
Hartmer R, Storm N, Boecker S, Rodi CP,
Hillenkamp F, Jurinke C and van den Boom D: RNase T1 mediated
base-specific cleavage and MALDI-TOF MS for high-throughput
comparative sequence analysis. Nucleic Acids Res. 31:e472003.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nakayama S, Sasaki A, Mese H, Alcalde RE
and Matsumura T: Establishment of high and low metastasis cell
lines derived from a human tongue squamous cell carcinoma. Invasion
Metastasis. 18:219–228. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tanikawa C, Urabe Y, Matsuo K, Kubo M,
Takahashi A, Ito H, Tajima K, Kamatani N, Nakamura Y and Matsuda K:
A genome-wide association study identifies two susceptibility loci
for duodenal ulcer in the Japanese population. Nat Genet.
44:430–434. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gu Z, Thomas G, Yamashiro J, Shintaku IP,
Dorey F, Raitano A, Witte ON, Said JW, Loda M and Reiter RE:
Prostate stem cell antigen (PSCA) expression increases with high
gleason score, advanced stage and bone metastasis in prostate
cancer. Oncogene. 19:1288–1296. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Reiter RE, Sato I, Thomas G, Qian J, Gu Z,
Watabe T, Loda M and Jenkins RB: Coamplification of prostate stem
cell antigen (PSCA) and MYC in locally advanced prostate cancer.
Genes Chromosomes Cancer. 27:95–103. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Reiter RE, Gu Z, Watabe T, Thomas G,
Szigeti K, Davis E, Wahl M, Nisitani S, Yamashiro J, Le Beau MM, et
al: Prostate stem cell antigen: A cell surface marker overexpressed
in prostate cancer. Proc Natl Acad Sci USA. 95:1735–1740. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Naz RK and Shiley B: Prophylactic vaccines
for prevention of prostate cancer. Front Biosci (Schol Ed).
4:932–940. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fu YP, Kohaar I, Rothman N, Earl J,
Figueroa JD, Ye Y, Malats N, Tang W, Liu L, Garcia-Closas M, et al:
Common genetic variants in the PSCA gene influence gene expression
and bladder cancer risk. Proc Natl Acad Sci USA. 109:4974–4979.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hao JY, Yang YL, Li S, Qian XL, Liu FF and
Fu L: PSCA expression in invasive micropapillary carcinoma of
breast. Zhonghua Bing Li Xue Za Zhi. 40:382–386. 2011.(In Chinese).
PubMed/NCBI
|
|
25
|
Wang D, Wang Z, Tian J, He X, Chowdhury
WH, Zhang X, Li S and Rodriguez R: Prostate stem cell antigen
enhancer and uroplakin II promoter based bladder cancer targeted
tissue-specific vector. Urol Oncol. 28:164–169. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ono H, Hiraoka N, Lee YS, Woo SM, Lee WJ,
Choi IJ, Saito A, Yanagihara K, Kanai Y, Ohnami S, et al: Prostate
stem cell antigen, a presumable organ-dependent tumor suppressor
gene, is down-regulated in gallbladder carcinogenesis. Genes
Chromosomes Cancer. 51:30–41. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
de Nooij-van Dalen AG, van Dongen GA,
Smeets SJ, Nieuwenhuis EJ, Stigter-van Walsum M, Snow GB and
Brakenhoff RH: Characterization of the human Ly-6 antigens, the
newly annotated member Ly-6K included, as molecular markers for
head-and-neck squamous cell carcinoma. Int J Cancer. 103:768–774.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bamezai A: Mouse Ly-6 proteins and their
extended family: Markers of cell differentiation and regulators of
cell signaling. Arch Immunol Ther Exp (Warsz). 52:255–266.
2004.PubMed/NCBI
|
|
29
|
Hruska M, Keefe J, Wert D, Tekinay AB,
Hulce JJ, Ibañez-Tallon I and Nishi R: Prostate stem cell antigen
is an endogenous lynx1-like prototoxin that antagonizes
alpha7-containing nicotinic receptors and prevents programmed cell
death of parasympathetic neurons. J Neurosci. 29:14847–14854. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jain A, Lam A, Vivanco I, Carey MF and
Reiter RE: Identification of an androgen-dependent enhancer within
the prostate stem cell antigen gene. Mol Endocrinol. 16:2323–2337.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bahrenberg G, Brauers A, Joost HG and
Jakse G: PSCA expression is regulated by phorbol ester and cell
adhesion in the bladder carcinoma cell line RT112. Cancer Lett.
168:37–43. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chapman EJ, Kelly G and Knowles MA: Genes
involved in differentiation, stem cell renewal, and tumorigenesis
are modulated in telomerase-immortalized human urothelial cells.
Mol Cancer Res. 6:1154–1168. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Saffran DC, Raitano AB, Hubert RS, Witte
ON, Reiter RE and Jakobovits A: Anti-PSCA mAbs inhibit tumor growth
and metastasis formation and prolong the survival of mice bearing
human prostate cancer xenografts. Proc Natl Acad Sci USA.
98:2658–2663. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gu Z, Yamashiro J, Kono E and Reiter RE:
Anti-prostate stem cell antigen monoclonal antibody 1G8 induces
cell death in vitro and inhibits tumor growth in vivo via a
Fc-independent mechanism. Cancer Res. 65:9495–9500. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Study Group of Millennium Genome Project
for Cancer, . Sakamoto H, Yoshimura K, Saeki N, Katai H, Shimoda T,
Matsuno Y, Saito D, Sugimura H, Tanioka F, et al: Genetic variation
in PSCA is associated with susceptibility to diffuse-type gastric
cancer. Nat Genet. 40:730–740. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yang L, Han Y, Saiz Suarez F and Minden
MD: A tumor suppressor and oncogene: The WT1 story. Leukemia.
21:868–876. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Radtke F and Raj K: The role of Notch in
tumorigenesis: Oncogene or tumour suppressor. Nat Rev Cancer.
3:756–767. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wu C, Wang G, Yang M, Huang L, Yu D, Tan W
and Lin D: Two genetic variants in prostate stem cell antigen and
gastric cancer susceptibility in a Chinese population. Mol
Carcinog. 48:1131–1138. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ou J, Li K, Ren H, Bai H, Zeng D and Zhang
C: Association and haplotype analysis of prostate stem cell antigen
with gastric cancer in Tibetans. DNA Cell Biol. 29:319–323. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Matsuo K, Tajima K, Suzuki T, Kawase T,
Watanabe M, Shitara K, Misawa K, Ito S, Sawaki A, Muro K, et al:
Association of prostate stem cell antigen gene polymorphisms with
the risk of stomach cancer in Japanese. Int J Cancer.
125:1961–1964. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang M, Bai J, Tan Y, Wang S, Tian Y, Gong
W, Zhou Y, Gao Y, Zhou J and Zhang Z: Genetic variant in PSCA
predicts survival of diffuse-type gastric cancer in a Chinese
population. Int J Cancer. 129:1207–1213. 2011. View Article : Google Scholar : PubMed/NCBI
|
